This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Vaidya, Rakhee
Item Type | Name |
Concept
|
Humans
|
Concept
|
Lymphoma, Large B-Cell, Diffuse
|
Concept
|
Blood Glucose
|
Concept
|
Survivors
|
Concept
|
Cell Transformation, Neoplastic
|
Concept
|
Aged
|
Concept
|
Proto-Oncogene Proteins c-bcl-2
|
Concept
|
Medical Records
|
Concept
|
Adolescent
|
Concept
|
Biopsy
|
Concept
|
Adult
|
Concept
|
Proto-Oncogene Proteins c-bcl-6
|
Concept
|
Lymphoma, Non-Hodgkin
|
Concept
|
Aged, 80 and over
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
Concept
|
Bone Marrow Examination
|
Concept
|
Benzodiazepines
|
Concept
|
Breast Neoplasms
|
Concept
|
B-Lymphocytes
|
Concept
|
Middle Aged
|
Concept
|
Blood Transfusion
|
Concept
|
Young Adult
|
Academic Article
|
Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (EPOCH) With or Without Rituximab as First-Line Therapy for Aggressive Non-Hodgkin Lymphoma.
|
Academic Article
|
Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study.
|
Academic Article
|
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements.
|
Academic Article
|
Benzodiazepine use in breast cancer survivors: findings from a consecutive series of 1,000 patients.
|
Academic Article
|
Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis.
|
Academic Article
|
Predictors of greater than 80% 2-year mortality in primary myelofibrosis: a Mayo Clinic study of 884 karyotypically annotated patients.
|
Academic Article
|
Mature survival data for 176 patients younger than 60 years with primary myelofibrosis diagnosed between 1976 and 2005: evidence for survival gains in recent years.
|
Academic Article
|
Monosomal karyotype in primary myelofibrosis is detrimental to both overall and leukemia-free survival.
|
Academic Article
|
DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.
|
Academic Article
|
Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.
|
- Lymphoma
- Large
- B
- Cell
- Diffuse